Its announcement will come around the heels of an analogous licensing arrangement offered in February to Adastra Labs, which experienced until finally now focused on crafting cannabis extracts. Adastra's license also permits it to create and provide psilocybin and psilocin – hallucinogens extra commonly often called magic mushrooms that generate